{"id":"W2810063204","doi":"10.1016/j.jval.2018.04.044","title":"Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1: A Canadian Cost-Utility Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Rilpivirine; Dolutegravir; Human immunodeficiency virus (HIV); Medicine; Virology; Antiretroviral therapy; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005363619,0.0002115998,0.0005443241,0.0005639297,0.0001541024,0.00002067755,0.00007326184,0.00007689483,0.0002333294],"category_scores_gemma":[0.0001273086,0.0001495555,0.00004564724,0.0009753375,0.00008926345,0.000044263,0.00003229459,0.0001447488,0.00005257795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004285274,"about_ca_system_score_gemma":0.000613377,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1929671,"about_ca_topic_score_gemma":0.3556478,"domain_scores_codex":[0.9981589,0.0001664859,0.0003516144,0.0005117332,0.0002187283,0.0005924879],"domain_scores_gemma":[0.9984477,0.0001606539,0.000062486,0.0003344541,0.00007952661,0.0009152171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003817823,0.0002030243,0.9883013,0.00009869412,0.0001486742,0.00009078065,0.003806037,0.0000444176,0.000007531212,0.00003849163,0.0007809437,0.006098277],"study_design_scores_gemma":[0.001559727,0.0008186417,0.9890153,0.0003154291,0.0001567112,0.00001979858,0.0002254849,0.003897816,0.00003129592,0.00001390921,0.003785791,0.0001600851],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844558,0.0001371964,0.0001601493,0.01262464,0.00002366844,0.001016396,0.00004938915,0.00004185502,0.001490967],"genre_scores_gemma":[0.992999,0.00007056443,0.004200396,0.001194284,0.00005542688,0.00006950984,0.000054323,0.00001486726,0.001341617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1626807,"threshold_uncertainty_score":0.812407,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02129407065361259,"score_gpt":0.2763232802801294,"score_spread":0.2550292096265168,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}